Orsted

Phase A — Understand the business

Lens 1 · Company Overview

Ørsted is the world's largest offshore-wind developer — it builds, owns, and operates offshore wind farms, and increasingly only offshore wind after a 2025 strategic retrenchment. The lineage matters: the company was DONG Energy (Danish Oil & Natural Gas), sold its upstream oil & gas to Ineos, rebranded Ørsted in 2017 (after physicist H.C. Ørsted), and IPO'd on Nasdaq Copenhagen in June 2016. The Danish State owns 50.1% and backstops the balance sheet; Equinor is the second-largest holder at ~10%.

How it makes money — three levers:

1. Electricity sales from operating assets: 10.2 GW installed offshore capacity at end-2025, plus onshore wind, solar, storage, and bioenergy for >18 GW total renewable. Offshore revenue is a mix of subsidised contracts (UK CfDs, feed-in schemes), long-term PPAs, and merchant/hedged power.
2. The farm-down (capital-recycling) model — see Lens 3. Ørsted develops and builds, then sells ~50% stakes to institutional investors, books a gain, and recycles the capital into the next project. This is the financial engine of the whole model.
3. Construction + long-term O&M service contracts on assets it has partially sold.

Scale of the build book: 8.1 GW under construction at end-2025 — the largest offshore construction portfolio in the industry, spanning the UK (Hornsea 3, 2.9 GW), the US (Sunrise Wind 924 MW, Revolution Wind 704 MW), Poland (Baltica 2, with PGE), Germany (Borkum Riffgrund 3, Gode Wind 3 ramping), and Taiwan (Greater Changhua 2b & 4).

Contract structure / key terms: revenue is largely contracted long-dated (20-year PPAs on US projects; 15-year UK CfDs) — low commodity risk once operating, but enormous upfront construction risk and sensitivity to interest rates (these are bond-like, rate-duration assets). The central payment-term fact: Ørsted's returns are set at bid/FID and locked for the asset's life, so a project bid at 2021 prices with 2023 costs is permanently impaired — which is exactly what happened in the US.

Lens 2 · Supply Chain

Offshore wind is a heavy-industrial supply chain with real chokepoints. Named stakeholders along Ørsted's chain:

Upstream inputs → Ørsted:

• Turbines (the critical input): primarily Siemens Gamesa (e.g. 94× SG DD-167 for Sunrise Wind; 107× 14 MW for Baltica 2 with PGE) and Vestas. This is a near-duopoly chokepoint for Western offshore — and Siemens Gamesa (parent Siemens Energy) has had well-publicised blade-quality and reliability problems, a live risk to Ørsted's availability and warranty economics even though no specific Ørsted-vs-Siemens suit surfaced in search.
• Monopile foundations: EEW, Sif Group, Steelwind (European fabricators). Sunrise Wind's cost overruns were explicitly tied to monopile foundations — a single-component blow-up drove a multi-billion-DKK impairment.
• Subsea cables: NKT, Prysmian, Nexans (manufacture); Jan De Nul (Belgian marine contractor) is laying Hornsea 3's 680 km of export cable.
• Installation vessels (WTIVs / cable-lay): Cadeler, Fred. Olsen Windcarrier, DEME, Jan De Nul. Purpose-built vessel scarcity is a persistent schedule chokepoint.

Ørsted → end customer: power flows via grid operators (National Grid in the UK, PJM/ISO-NE in the US) to offtakers — utilities and states under PPAs/CfDs, plus corporate PPAs.

Chokepoints / single-source dependencies:

• Grid connection is a live single-point failure: a National Grid connection delay pushed Hornsea 3 first power to Q1 2027, commissioning into the Q4 2027–Q1 2028 window. Ørsted has been compensated for a similar German grid delay (Borkum Riffgrund 3).
• Turbine OEM concentration (Siemens Gamesa/Vestas) — no cheap Western alternative; Chinese OEMs are excluded from these markets.
• US Jones Act constrains vessel availability for US projects, inflating cost.

Names present, so this lens holds — the supply chain is real, industrial, and its failure modes (monopiles, grid, vessels, turbine quality) are precisely where the last three years of impairments came from.

Lens 3 · Competitive Advantages (moats)

The genuine moats:

• Scale + track record as the #1 offshore developer: ~10 GW installed is a real experience curve — Ørsted has commissioned more offshore capacity than anyone. This is the moat bulls lean on.
• The farm-down machine / access to institutional capital: Ørsted has a repeatable channel to sell de-risked operating stakes to pension and infra funds (Schroders Greencoat took 24.5% of West of Duddon Sands for ~£456m / DKK 4bn, closed Apr-2025; Stonepeak, Energy Capital Partners took US onshore/solar/storage stakes). When it works, it is a low-cost capital moat.
• Development pipeline + seabed rights in scarce, permitted zones (UK, Baltic, Taiwan).
• Sovereign backstop: the Danish State's 50.1% is a structural credit moat — it underwrote its pro-rata of the DKK 60bn raise, which no private developer could replicate.

The moat is thinner than the "world leader" label suggests — and 2025 exposed it:

• The farm-down moat is contingent, not durable. The defining event of 2025: Ørsted could not farm down 50% of Sunrise Wind on acceptable terms amid US policy risk, so it retained 100% and funded the ~DKK 40bn incremental construction cost via the rights issue. A "moat" that evaporates when rates rise and policy turns is a fair-weather moat.
• Bargaining power runs the wrong way. Ørsted needs the turbine duopoly more than it needs Ørsted; it needs grid operators and permitting regimes more than they need it; and its construction track record has deteriorated enough that rating agencies cite it explicitly (Moody's flagged "deterioration of the company's track record in delivering construction projects on time and to budget").
• Switching costs / network effects: essentially none. Power is a commodity; the moat is cost-of-capital and execution, not customer lock-in.

Verdict on the moat: real scale advantage, but it is an execution-and-financing moat, not a pricing moat — and both legs bent badly in 2023–25. The durable edge is the sovereign backstop + pipeline; the fragile edge is the farm-down model's dependence on benign rates and policy.

Lens 4 · Segments

Ørsted reports three segments: Offshore, Onshore (wind & solar & storage), and Bioenergy & Other. segments.csv is empty, so all figures are ``:

Geography: Europe (UK — the single biggest market via Hornsea; Germany; Denmark; Poland), North America (the problem child — Sunrise, Revolution; Ocean Wind cancelled), and Asia-Pacific (Taiwan — Greater Changhua). The 2025 strategy explicitly narrows to "offshore wind in Europe and select Asia-Pacific markets", i.e. a managed retreat from US growth (while finishing the US assets under construction).

The trend that matters: offshore generation +6% in 2025 vs 2024 despite below-normal wind speeds (availability + Gode Wind 3 ramp), then +27% YoY in Q1 2026 as Borkum Riffgrund 3 and Greater Changhua 4 ramped. The operating business is accelerating even as the strategic footprint shrinks — that divergence is the core of the story.

---

Phase B — Measure performance

Lens 5 · Earnings Result

FY2025 (reported 2026-02-06) — the "we survived" print:

• EBITDA excl. new partnerships & cancellation fees: DKK 25.1bn, inside the DKK 24–27bn guide. EBITDA incl. partnerships & cancellation fees: DKK 22.4bn (the gap = fewer/lower farm-down gains + cancellation costs).
• Profit for the year: DKK 3.2bn, "DKK 3.2bn higher than 2024" → implies 2024 ≈ breakeven. (Context: 2023 was a ~DKK 20bn loss after DKK 28.4bn impairments.)
• Interest-bearing net debt: DKK 19.0bn at end-2025 — the headline of the whole thesis. Post rights-issue (DKK 60bn) + farm-downs, net debt/EBITDA ≈ 0.76x. On reported NIBD the balance sheet is now under-levered — a stunning turn from the 2023–24 stress. (Caveat in Lens 10: rating-agency-adjusted net debt, which adds hybrids/leases/decommissioning, is materially higher — which is why S&P/Moody's still worry.)
• Capacity: 10.2 GW offshore installed, 8.1 GW under construction.

Q1 2026 (reported 2026-05):

• EBITDA excl. partnerships/cancellation: DKK 9.5bn, up >10% YoY; offshore EBITDA DKK 7.5bn; offshore generation +27% YoY.
• Net profit DKK 2.6bn (≈ $412m), down 46% YoY — driven by non-cash, US interest-rate-related impairments. The pattern persists: strong operations, impairment-noisy bottom line.
• Milestones: first power at Revolution Wind; first turbines at Sunrise Wind; Hornsea 3, Baltica 2, Greater Changhua 2b/4 advancing.
• Guidance kept: FY2026 EBITDA "more than DKK 28bn" (a conservative floor) vs the DKK 29–33bn business-plan range; gross investment DKK 50–55bn.

Read: the numbers say the operating business is healthy and growing, the balance sheet is repaired, and the remaining drag is legacy US impairment noise — not cash losses. The market reaction across 2026 has been a re-rating up (see Lens 8).

Lens 6 · Earnings Calls (sentiment trend)

No transcripts on the shelf; sentiment is inferred from management language across the FY2024 → FY2025 → Q1 2026 cycle:

• Early 2025 (FY2024, Jan/Feb): crisis tone — DKK 12.1bn fresh impairment, CEO change (Nipper out, Errboe in), the 35–38 GW-by-2030 and DKK 39–43bn-EBITDA-by-2030 targets scrapped, dividend suspended, capex cut ~25%. The language is triage: "value-focused capital allocation," "stricter capital allocation."
• Aug 2025 (H1, rights issue): capitulation-and-reset tone — the DKK 60bn raise is announced because the Sunrise farm-down failed. Framed as decisive de-risking; the market read it as forced (shares −20–29%).
• FY2025 (Feb 2026): confidence returning — "a stronger and more competitive Ørsted," four strategic priorities (balance sheet, deliver 8.1 GW, disciplined capital allocation, competitiveness), and crucially: "we now have financial flexibility to pursue attractive offshore wind opportunities."
• Q1 2026 (May): operational-momentum tone — +27% generation, guidance reaffirmed, US legal wins framed as validation.

Phrases that appeared: "disciplined," "value-focused," "financial flexibility," "competitive." Phrases that disappeared: the aspirational 2030 GW/EBITDA targets, "global leader in green energy," dividend commitments. The arc is triage → capitulation → guarded confidence — a textbook restructuring narrative, and the tone genuinely improved as the balance sheet and courts co-operated.

Lens 7 · Comps

Peer set = large offshore-exposed developers/utilities. Multiples are `` where sourced; n/a otherwise (no fabrication).

Read: Ørsted at ~8.5x trailing / ~7x forward EV/EBITDA trades below Iberdrola (10.9x) and well below NextEra (18.3x) — a discount that reflects (a) US policy risk, (b) execution track record, (c) lower structural growth after the 2030 target cut, and (d) zero dividend (vs yield-paying peers). The discount is deserved but not extreme; the question is whether it's a value trap or a re-rating candidate. Note the reported-NIBD EV understates true EV (hybrids/leases add to rating-agency debt), so true EV/EBITDA is a touch higher than 8.5x.

Lens 8 · Stock-Price Catalysts (moves >5%, last ~5y)

The tape tells you exactly what this stock reacts to: US policy, impairments, and capital structure — not routine earnings.

• Jan 8 2021 — all-time high DKK 778. The ESG/green-bubble peak.
• Nov 1 2023 — ~−25% in a day: ceased Ocean Wind 1 & 2 (NJ), took DKK 28.4bn impairment, FID on Revolution Wind.
• Jan 21 2025 — down again: fresh DKK 12.1bn (~$1.7bn) US impairment (Sunrise costs, seabed leases) — "Trump nightmare begins".
• Feb 2025 — reset: 2030 targets scrapped, dividend suspended, capex −25%.
• Aug 11 2025 — ~−20% to −29%: DKK 60bn rights issue announced (forced by the failed Sunrise farm-down + Trump stop-work risk). All-time-low territory ~DKK 90–100 in late Aug 2025.
• Sep 22 2025 — pop: Judge Lamberth enjoins the first Revolution Wind stop-work order; work resumes.
• Oct 6 2025 — rights issue completes, DKK 59.56bn raised, 99.3% subscribed.
• Dec 22 2025 → Jan 13 2026 — second stop-work order, then second injunction: court again clears Revolution Wind to resume. Stock re-rated up on the legal wins.
• 2026 YTD — recovery to ~DKK 147–165; ~+50–65% off the Sep-2025 lows; multiple broker upgrades (Goldman → Buy DKK 185; Morgan Stanley → OW DKK 225).

What the market actually reacts to: (1) US federal policy (stop-work orders vs court injunctions) — the single biggest swing factor; (2) impairments; (3) the capital structure (dilution). Routine generation beats barely move it. This is a policy-and-solvency stock, and both of those overhangs have improved since Sep-2025 — which is why it's up.

---

Phase C — Judge people & books

Lens 9 · Management

• CEO — Rasmus Errboe (since early 2025). Internal promotion: Deputy CEO/CCO (2024), interim CFO (2023–24), long-time Ørsted regional/commercial leader. He is the restructuring CEO who scrapped the growth targets, ran the rights issue, and narrowed the company to offshore. Track record: too early to judge as CEO, but he has executed the triage credibly — balance sheet repaired, guidance met two years running, US legal strategy working. Not a founder; a professional operator handed a turnaround.
• CFO — Trond Westlie (since Apr 2024). A serious restructuring/heavy-industry CFO: ex-CFO of A.P. Møller-Maersk (2010–16), Telenor, VEON, Aker. Precisely the CV you want for a balance-sheet crisis — deleveraging, disposals, capital raises. His fingerprints are on the DKK 19bn net-debt outcome.
• Chair — Lene Skole (since Mar 2024). Oversaw the CEO transition and the raise.
• Ownership / skin in the game: dominated by Danish State (50.1%) and Equinor (~10%). Insider management ownership is small (typical of a state-controlled European utility) — insider-transactions.csv absent, so n/a. The alignment here is sovereign, not entrepreneurial: the State's interest is Danish industrial/climate policy + not losing money, which cuts both ways for minority holders. Equinor nominating a board member (2025) adds an industrial oil-major discipline voice.
• Capital-allocation history — the crux: the prior regime (Nipper) over-committed to US growth at 2021 economics and destroyed enormous value (cumulative US impairments DKK 28.4bn (2023) + DKK 12.1bn (2024) + ongoing rate charges — call it >DKK 45bn of US value destruction ). The current regime is doing the opposite — retrench, farm-down, raise equity, target ROCE 11–13% and 150–300 bps IRR spread to WACC at every FID. Red flags: none of fraud type; the flag is a structurally poor construction/forecasting track record (Moody's-cited) and a governance structure where the controlling shareholder is a government.

Read: the right people are now in the right seats for this phase (a restructuring CFO + a disciplined operator CEO), but they inherited a value-destruction record and a business whose returns are hostage to rates and politics they don't control.

Lens 10 · Forensic Red Flags

financials.csv is empty, so this is qualitative + ``. Accounting/where-the-bodies-are:

• Impairment recidivism is the #1 flag. Three consecutive years of large US write-downs (2023 DKK 28.4bn; 2024 DKK 12.1bn; 2025–Q1 2026 ongoing rate-driven charges). Each was "non-cash," but they are the cash of prior years crystallising as bad. Impairments are the tell that FID underwriting was too optimistic. Watch whether the remaining US book (Sunrise 100%-owned, Revolution) takes further charges — Sunrise's monopile overruns are not obviously over.
• Reported net debt (DKK 19.0bn) flatters the true leverage. Rating agencies adjust upward for hybrid capital, lease liabilities, decommissioning/ARO, and 50%-owned partnership debt. This is why, even at <1x reported net-debt/EBITDA, Moody's sits at Baa2 (wants FFO/net debt "low-20s%") and S&P at BBB negative (wants FFO/debt ≥25%). The gap between the DKK 19bn headline and the agency view is the single most important thing a careless reader will miss.
• Farm-down gains inflate "headline" EBITDA quality. The DKK 25.1bn (excl. partnerships) vs DKK 22.4bn (incl.) split shows management steering readers to the ex-partnership figure. Divestment gains are lumpy, non-recurring, and dependent on a willing institutional-capital market — treat them as below-the-line, not core earnings.
• Construction-in-progress / capitalised interest: with DKK 50–55bn/yr gross investment against ~DKK 30bn EBITDA, a large share of value sits in balance-sheet CWIP carried at management's cost/return assumptions — the exact place the impairments came from.
• Grid-delay compensation (Borkum Riffgrund 3) is booked as income — legitimate, but a reminder that a chunk of "earnings" is contractual make-whole, not generation.

Regulatory findings (required sub-section).

• SEC (EDGAR LR + AAER): None possible — Ørsted has no CIK and is not an SEC filer. Per regulatory/regulatory-findings.md: "Ørsted has no CIK — it is public and not required to file with the SEC. No EDGAR enforcement search is possible."
• US federal action (the material legal matter): the Revolution Wind stop-work litigation — BOEM/Interior issued stop-work orders Aug 22 2025 and again Dec 22 2025; Ørsted + JV partner Skyborn Renewables (GIP/BlackRock) sued; the US District Court (DC) granted preliminary injunctions in Sep-2025 and Jan-2026, allowing construction to continue. This is government action against the company's asset, not enforcement against the company — a policy/expropriation-risk item, and it is ongoing.
• Non-SEC enforcement (FTC/DOJ/FDA/etc.): no material fines/consent-decrees surfaced. A Business & Human Rights Resource Centre entry references a US wind-farm-related suit (community/environmental), immaterial.
• Supplier-side risk (not an Ørsted liability): Siemens Gamesa/Siemens Energy blade-quality issues create warranty/availability exposure for Ørsted's fleet, but no Ørsted-vs-Siemens litigation was found.
• Summary: No accounting fraud or securities-enforcement findings — verified via the empty SEC EFTS result (no CIK) + web search as of 2026-07-10. The material legal exposure is the ongoing US government stop-work litigation (courts have sided with Ørsted twice), and the material accounting flag is three years of US impairment recidivism plus rating-agency net-debt adjustments that dwarf the DKK 19bn reported figure.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection

Ørsted guides in EBITDA, and for a rate-sensitive developer EBITDA/ROCE are more meaningful than EPS — so I lead with the EBITDA path and give a rough EPS bridge. All forward figures ``; no forecast.ts entry logged (watchlist rule).

Base-case EBITDA path (excl. partnerships/cancellation):

Rough EPS bridge (base): on ~1,321m shares post-raise, a clean (ex-impairment) net income of ~DKK 6–8bn in 2026 → EPS ~DKK 4.5–6.0. Reported EPS will stay noisy while US rate-driven impairments recur. Bull EPS ~DKK 7–8 (clean delivery, farm-down gains, dividend restored); bear EPS ~DKK 2–3 (further impairment + cost overrun).

The input lines that swing it: (1) construction cost-control on Sunrise/Hornsea 3 (history: bad); (2) interest rates (every 100 bps of long rates moves both impairments and the DCF materially); (3) farm-down market depth (institutional appetite for offshore stakes); (4) US legal outcomes on Revolution; (5) whether AR7-style higher strike prices (£91/MWh) flow into new FIDs — the single most bullish input.

Lens 12 · Bull vs Bear

Bull case. The solvency crisis is over — net debt DKK 19.0bn, <1x EBITDA, rights issue done, Danish State + Equinor both subscribed. Offshore economics have demonstrably reset higher: UK AR7 (Jan-2026) cleared at £91/MWh vs ~£37–58 in prior rounds, so the new book is underwritten at economics that actually clear Ørsted's 11–13% ROCE / 150–300 bps-over-WACC hurdle — unlike the 2021-vintage US projects that caused the pain. Operations are accelerating (+27% Q1 generation), the 8.1 GW build is the industry's largest, dividend reinstatement is targeted for FY2026 (a confidence signal), and the stock still trades at a discount to Iberdrola/NextEra. If Errboe/Westlie deliver the build cleanly, this re-rates toward peer multiples.

Bear case (permanent-impairment risks). (1) Execution: Ørsted's construction/forecasting track record is genuinely poor (Moody's-cited); one more Sunrise-style monopile/cost blow-up on a 100%-owned US asset hits equity directly (no partner to share it). (2) US policy as expropriation: the administration has issued stop-work orders twice; courts have held so far, but the litigation is unresolved and runs into the 2028 election — a hostile federal posture can strand the US portfolio regardless of contracts. (3) The farm-down model is structurally impaired at higher rates — if institutional bids stay weak, Ørsted must fund more builds on balance sheet (as it did for Sunrise), pressuring the just-repaired leverage and the FFO/debt ratios the agencies watch.

Pre-mortem (it's Jan-2028, thesis broke): most likely story — a fresh multi-billion impairment on Sunrise/Revolution (cost overrun or an adverse final US ruling) reignites balance-sheet fear just as rates stay higher-for-longer, the farm-down market stays shut, and the FY2026 "reinstated" dividend gets cut again. The stock round-trips to the DKK 90s and the "repair" narrative is discredited.

Are multiples too high? No — ~7x forward EV/EBITDA is not demanding for a repaired balance sheet with reset economics. The risk is earnings/asset impairment, not multiple compression.

Contrarian view (what the market refuses to see): consensus is anchored on US policy headlines and treats Ørsted as a broken growth story — but the balance sheet is now under-levered on reported net debt, and AR7 quietly proved the sector's economics have repriced upward. The market is fighting the last war (solvency) while the actual 2026–28 question is mundane execution. That asymmetry is why the stock has already run ~50%+ off the lows — and why the easy money is likely made.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case:

• "Repaired balance sheet" is a reported-number illusion. DKK 19bn NIBD ignores the hybrids, leases, ARO, and partnership debt that push rating-agency-adjusted net debt far higher — which is why both agencies still sit one-to-two notches into worry (Baa2 / BBB-negative) despite the raise. The equity was raised to defend the rating, not to create headroom for shareholders.
• The farm-down model — the entire value-creation engine — broke in public. They could not sell 50% of Sunrise Wind and had to dilute holders 68% (900.8m new shares on ~420m) to fund it. If that engine is structurally impaired by higher rates, every future build carries the same dilution/leverage risk.
• Revenue is concentrated in exactly the wrong place politically. The US assets are the biggest impairment source and the target of a hostile federal government that has twice ordered work stopped. Court injunctions are not final judgments; a bad ruling or a second Trump term compounds the loss.
• Most dangerous competitor bulls underestimate: not another developer — it's the risk-free rate. These are bond-proxy assets; 5% long rates permanently lower NPV and were the true cause of the impairments. Ørsted "competes" against Bunds/Treasuries for capital and loses when rates are high.
• Worst capital-allocation moves: the entire 2019–22 US expansion at bubble-era economics — >DKK 45bn destroyed. Trusting the same institution to now compound at 11–13% requires forgetting recent history.
• If growth disappoints 20–30%: the DKK 34–37bn 2027–28 EBITDA estimates fall to ~DKK 27–30bn; with dividend restored and capex committed, FFO/debt slips back below agency thresholds → downgrade risk → the discount widens, not narrows.
• Single scenario that permanently impairs: a final adverse US ruling stranding Revolution/Sunrise plus a shut farm-down market — plausibility moderate (courts have leaned Ørsted's way, but the political risk is real through 2028).

Lens 14 · Management Questions (ordered by information value)

1. On a rating-agency-adjusted basis (incl. hybrids, leases, ARO, partnership debt), what is FFO/net-debt today and through 2028, and what headroom exists to the Baa2/BBB thresholds before the reinstated dividend?
2. Sunrise Wind is now 100%-owned after the farm-down failed — what is the remaining cost-to-complete range, and what monopile/foundation contingency is in the current carrying value?
3. If a US federal court issues a final ruling adverse to Revolution Wind, what is the maximum equity impairment, and is it ring-fenced from the Danish parent?
4. What specific evidence do you have that the farm-down market has reopened at values that clear your hurdle — name recent closed transactions and implied multiples.
5. At AR7-level strike prices (£91/MWh), what unlevered lifecycle IRR do new FIDs actually generate, and how much of your pipeline can be bid at those economics?
6. You target dividend reinstatement for FY2026 — what net-debt and FFO/debt trigger would cause you to defer it again?
7. How much of 2026–28 EBITDA depends on non-recurring farm-down gains vs recurring generation, quarter by quarter?
8. What is the true remaining US growth ambition — are you finishing the current book and exiting US new-build entirely?
9. Turbine supply is a Siemens Gamesa/Vestas duopoly with known quality issues — what is your warranty/availability exposure and second-source strategy?
10. What ROCE did the 2019–22 US vintage actually deliver vs underwriting, and what has changed in your FID governance to prevent a repeat?
11. Grid delays (Hornsea 3, Borkum) keep pushing commissioning — how much 2027–28 EBITDA is at risk from grid/interconnection timing you don't control?
12. How does a sustained 5%+ long-rate environment change your 2030 build economics and asset carrying values?
13. What is the Danish State's stated position on future capital raises — is there a limit to sovereign backstop, and does Equinor's board seat change strategy?
14. Which assets in the current portfolio are candidates for outright sale (not farm-down) if leverage tightens?
15. What is the single internal metric you now manage the company to that you did not three years ago?

---